STOCK TITAN

Sharps Technology to Present at the Aegis Capital Corp. 2025 Virtual Conference on May 22nd

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Sharps Technology (NASDAQ: STSS), a medical device and pharmaceutical packaging company specializing in smart-safety syringe products, announced that CEO Robert Hayes will present at the Aegis Capital Corp. 2025 Virtual Conference on May 22, 2025, at 1:00 p.m. ET.

The company focuses on ultra-low waste capabilities with passive and active safety features in their syringe technologies. Sharps also offers products with specialized copolymer technology for the prefillable syringe market segment and operates a manufacturing facility in Hungary.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

-7.07% News Effect

On the day this news was published, STSS declined 7.07%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Presentation to be webcast at 1:00 p.m. ET

NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety syringe products to the healthcare industry, today announced that Robert Hayes, CEO, is scheduled to present at the Aegis Capital Corp. 2025 Virtual Conference on May 22, 2025 at 1:00 p.m. ET.

Presentation Details:

  • Presenter: Robert Hayes, CEO
  • Date: May 22, 2025
  • Time: 1:00 p.m. ET
  • Webcast: Register Here

About Sharps Technology:
Sharps Technology is an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety syringe products to the healthcare industry. The Company’s product lines focus on providing ultra-low waste capabilities, that incorporate syringe technologies that use both passive and active safety features. Sharps also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. The Company has a manufacturing facility in Hungary. For additional information, please visit www.sharpstechnology.com.

FORWARD-LOOKING STATEMENTS:
This press release contains “forward-looking statements”. Forward-looking statements reflect our current view about future events. When used in this press release, the words “anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,” “plan,” “poised” or the negative of these terms and similar expressions, as they relate to us or our management, identify forward-looking statements. Such statements, include, but are not limited to, statements contained in this press release relating to our business strategy, our future operating results and liquidity, and capital resources outlook. Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance. We caution you therefore against relying on any of these forward-looking statements. Important factors that could cause actual results to differ materially from those in the forward-looking statements include, without limitation, our ability to raise capital to fund continuing operations; our ability to protect our intellectual property rights; the impact of any infringement actions or other litigation brought against us; competition from other providers and products; our ability to develop and commercialize products and services; changes in government regulation; our ability to complete capital raising transactions; and other factors relating to our industry, our operations and results of operations. Actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We cannot guarantee future results, levels of activity, performance, or achievements. The Company assumes no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release.

Investor Contact:
Holdsworth Partners
Adam Holdsworth
Phone: 917-497-9287
Email: IR@sharpstechnology.com


FAQ

When is Sharps Technology (STSS) presenting at the Aegis Capital Corp. Conference?

Sharps Technology's CEO Robert Hayes is presenting at the Aegis Capital Corp. Virtual Conference on May 22, 2025, at 1:00 p.m. ET.

What are the main products of Sharps Technology (STSS)?

Sharps Technology specializes in smart-safety syringe products with ultra-low waste capabilities, featuring both passive and active safety features, and specialized copolymer technology for prefillable syringes.

Where does Sharps Technology (STSS) manufacture its products?

Sharps Technology operates a manufacturing facility in Hungary.

What stock exchange is Sharps Technology listed on?

Sharps Technology is listed on NASDAQ under the symbols STSS and STSSW.
Sharps Tech

NASDAQ:STSS

STSS Rankings

STSS Latest News

STSS Latest SEC Filings

STSS Stock Data

63.79M
28.19M
0.08%
0.07%
2.79%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
MELVILLE